Two Doses of BNT162b2 Vaccine Protect Against MIS-C
TUESDAY, Jan. 11, 2022 (HealthDay News) -- Receipt of two doses of the Pfizer-BioNTech vaccine is associated with a high level of protection against multisystem inflammatory syndrome in children (MIS-C) among children aged 12 to 18 years, according to research published in the Jan. 7 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Laura D. Zambrano, Ph.D., from the CDC COVID-19 Response Team, and colleagues used a test-negative case-control design to assess the effectiveness of two doses of the Pfizer-BioNTech vaccine received ≥28 days before hospital admission in preventing MIS-C among hospitalized patients aged 12 to 18 years at 24 pediatric hospitals in 20 states during July 1 to Dec. 9, 2021. Patients with MIS-C were matched to test-negative controls with at least one COVID-19-like symptom and negative severe acute respiratory syndrome coronavirus 2 polymerase chain reaction assay or antigen-based assay results and syndrome-negative controls without COVID-19-like illness. A total of 102 MIS-C case patients and 181 hospitalized controls were included.
The researchers found that the estimated effectiveness of two doses of the Pfizer-BioNTech vaccine was 91 percent against MIS-C. Of the 102 MIS-C case patients, five were fully vaccinated and 97 were unvaccinated. All 38 MIS-C patients who required life support were unvaccinated.
"This analysis lends supportive evidence that vaccination of children and adolescents is highly protective against MIS-C and COVID-19 and underscores the importance of vaccination of all eligible children," the authors write.
Several authors disclosed financial ties to the biopharmaceutical industry.
Related Posts
Meta-Analysis Shows Decrease in Dementia Risk With HTN Treatment
WEDNESDAY, Nov. 2, 2022 (HealthDay News) -- Antihypertensive treatment is...
Remdesivir Offers Some Benefit for Hospitalized COVID-19 Patients
TUESDAY, Feb. 1, 2022 (HealthDay News) -- Among hospitalized COVID-19 patients,...
En invierno, las personas pasan más tiempo en sueño MOR
VIERNES, 17 de febrero de 2023 (HealthDay News) -- Los cambios en la temperatura...
Avoidable Hospital Admissions Increased With Health Care Disruption
FRIDAY, July 21, 2023 (HealthDay News) -- People whose access to health care was...